Fear of progression in advanced cancer patients with prolonged survival on ongoing cancer treatment in an era of personalized medicine

Fear of progression in advanced cancer patients with prolonged survival on ongoing cancer treatment in an era of personalized medicine - PERSPECTIVES

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON51095

Enrollment

200

Registered

2021-07-22

Start date

2021-12-09

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced cancer fear (of progression) psychosocial wellbeing

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Adult patients with any type of advanced/metastasized/incurable cancer; • Receiving (ongoing) palliative systemic treatment (chemotherapy, hormonal therapy, targeted therapy, immunotherapy); • Prognosis > 12 months; • Able to fill in digital questionnaires; • Sufficient command of Dutch language.

Exclusion criteria

Exclusion criteria: • The inability to give informed consent; • Too ill to participate; • Concurrent participation in another questionnaire study on quality of life/psychological functioning.

Design outcomes

Primary

Measure	Time frame
Fear of progression	—

Secondary

Measure	Time frame
Uncertainty	—

Countries

Netherlands

Outcome results